Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
On January 12, 2026, Boston Scientific Corporation (NYSE:BSX) shared an expansion update, announcing a definitive agreement to acquire Valencia Technologies. With this move, the company expands its Urology franchise into implantable tibial nerve stimulation (ITNS) with the FDA-approved eCoin System. The deal focuses on overactive bladder, a large and underpenetrated market, consisting of nearly 30 million U.S. adults over 40 experiencing bothersome symptoms. However, only 19% of those adults receive treatment beyond lifestyle adjustments. eCoin features a coin-sized, minimally invasive implant, which broadens the company's pelvic health continuum and complements existing neuromodulation and urology offerings. At the same time, it addresses patients who are refractory to or intolerant of conservative therapies. Meanwhile, clinical validation strengthens the case for Boston Scientific Corporation (NYSE:BSX), with 68% of patients in the pivotal trial recording at least a 50% reduction
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Podcast: JPM26's dealmaking falls short of expectations [Yahoo! Finance]Yahoo! Finance
- Notable healthcare headlines for the week: Eli Lilly, UnitedHealth, and Boston Scientific in focus [Seeking Alpha]Seeking Alpha
- Is Boston Scientific Corporation (NYSE:BSX) Worth US$88.1 Based On Its Intrinsic Value? [Yahoo! Finance]Yahoo! Finance
- Boston Scientific to acquire Penumbra for $14.5B [Yahoo! Finance]Yahoo! Finance
- Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PENPR Newswire
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 1/15/26 - Form 8-K
- 1/15/26 - Form 8-K
- 12/8/25 - Form 3
- BSX's page on the SEC website